News and Publishing Service for Cannabis Related, Canadian Companies
Contact us:
905.674.5977
twitter
facebook
linkedin
News and Publishing Service for Cannabis Related, Canadian Companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
Cannabis News
Lift Toronto 2023 Cannabis Conference & Expo Promises to Energize, Inspire, Educate, and Motivate Audiences
Lexaria Bioscience Corp. (NASDAQ: LEXX) Banking on DehydraTECH(TM) Technology for Major 2024 Growth
BizCann Expo: An Elite Business & Networking Event for All Things Cannabis
New England Cannabis Convention To Be Held In Boston, MA
Alternative Products Expo: Innovation and Sustainability
CannabisNewsBreaks
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO
Lexaria Bioscience Corp. (LEXX)
March 14, 2024
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot Study
Lexaria Bioscience Corp. (LEXX)
March 7, 2024
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Commence Diabetes and Weight Loss Animal Study
Lexaria Bioscience Corp. (LEXX)
March 5, 2024
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Commence HYPER-H23-1 Clinical Trial
Lexaria Bioscience Corp. (LEXX)
March 1, 2024
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6M Registered Direct Offering
Lexaria Bioscience Corp. (LEXX)
February 20, 2024
View More CannabisNewsBreaks
CanadianCannabisWire Articles
Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Huge 2024 Milestone with FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial
Lexaria Bioscience Corp. (LEXX)
March 18, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Banking on DehydraTECH(TM) Technology for Major 2024 Growth
Lexaria Bioscience Corp. (LEXX)
March 8, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering
Lexaria Bioscience Corp. (LEXX)
February 27, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Doubles Down on GLP-1 Clinical Studies for 2024; Terms 2023 as its Most Successful and Active Year of R&D
Lexaria Bioscience Corp. (LEXX)
February 20, 2024
New England Cannabis Convention To Be Held In Boston, MA
NECANN
February 15, 2024
View All CanadianCannabisWire Articles
CannabisNewsAudio
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expanding its Footprint in the Booming Legal Marijuana Market
Wildflower Brands Inc. (WLDFF)
April 26, 2019
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Set to Profit from CBD Market Growth via Recent Distribution Agreements
Wildflower Brands Inc. (WLDFF)
April 12, 2019
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Ideally Positioned as the Healing Power of CBD Gains Awareness
Wildflower Brands Inc. (WLDFF)
March 29, 2019
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Poised to Benefit from Soaring CBD Market
Wildflower Brands Inc. (WLDFF)
March 25, 2019
CannabisNewsAudio – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Positioned to Benefit from the Rise of CBD Beverages
Phivida Holdings Inc. (PHVAF)
March 22, 2019
View All CannabisNewsAudio
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
CanadianCannabisWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
905.674.5977